KYNB
KYNB
NASDAQ · Biotechnology

Kyntra Bio Inc

$8.22
+0.72 (+9.60%)
As of Feb 8, 2:21 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 6.10M 5.44M 5.56M
Net Income -1,470,070 -1,283,535 -1,495,769
EPS
Profit Margin -24.1% -23.6% -26.9%
Rev Growth +9.0% +18.0% +2.0%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 13.84M 11.14M 12.70M
Total Equity 22.33M 24.70M 26.50M
D/E Ratio 0.62 0.45 0.48
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -2,132,580 -2,024,078 -1,912,875
Free Cash Flow -1,039,733 -1,099,827 -902,858